Moderator: Dr. Kevin Girard, Pfizer
Moderator: Dr. Christopher Burcham, Eli Lilly and Company
Particle surface engineering is a cost-effective, promising route to achieve enhancements in the flowability, bulk density and other properties of a variety of cohesive active pharmaceutical ingredients (APIs). This...
In solution phase crystallisation processes, understanding and controlling the transition pathway associated with the assembly of molecules from their solvated state, into three-dimensional, ordered crystalline-solids, represents a significant grand...
Dr. Alfred Lee, Merck Research Laboratories
Dr. Shawn Yin, Bristol Myers Squibb
Drs. Chandler Greenwell (XtalPi), Harsh Shah (J-Star), and Jessica Bruhn (NIS)
